DUSP1 and pancreatic neoplasm: Using a doxycycline-inducible strategy to suppress DUSP1 in established orthotopic pancreatic tumors, we show that combining gemcitabine with DUSP1 inhibition prolongs survival, attenuates angiogenesis, and enhances apoptotic cell death.